Luckwel Pharmaceuticals Inc. (LWEL) financial statements (2022 and earlier)

Company profile

Business Address 125 CAMBRIDGE PARK DRIVE
CAMBRIDGE, MA 02140
State of Incorp. NV
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
2/29/2016
2/28/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2026192911748
Cash and cash equivalents2026192911748
Other undisclosed current assets    180 
Total current assets:2026194711748
Noncurrent Assets
Intangible assets, net (including goodwill)     (55)(37)
Intangible assets, net (excluding goodwill)     (55)(37)
Other noncurrent assets    5  
Other undisclosed noncurrent assets     55 
Total noncurrent assets:    5 (37)
Other undisclosed assets45172   46
TOTAL ASSETS:471727195211757
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:44022268666812
Accrued liabilities758     
Employee-related liabilities293144  32732390
Taxes payable7370     
Other undisclosed accounts payable and accrued liabilities  6866(260)(31)(388)
Debt15      
Due to related parties351,12375182327  
Other undisclosed current liabilities     32 
Total current liabilities:4901,345819148395332
Noncurrent Liabilities
Other undisclosed liabilities1     390
Total liabilities:4911,34581914839533393
Stockholders' equity
Stockholders' equity attributable to parent, including:(444)(1,328)(792)(129)(342)84(526)
Common stock1,4671,4341,434184176175105
Additional paid in capital1,7534664661,71697385686
Accumulated other comprehensive income0000000
Accumulated deficit(3,664)(3,228)(2,691)(2,029)(1,492)(947)(526)
Other undisclosed stockholders' equity attributable to parent      (191)
Other undisclosed stockholders' equity      191
Total stockholders' equity:(444)(1,328)(792)(129)(342)84(335)
TOTAL LIABILITIES AND EQUITY:471727195211757

Income statement (P&L) ($ in thousands)

3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
2/29/2016
2/28/2015
Revenues  0  0 
Other income  0 (60)0
Gross profit:  0  0 
Operating expenses(435)(536)(623)(533)(451)(421)(293)
Operating loss:(435)(536)(623)(533)(511)(421)(293)
Nonoperating expense(1)  (4)   
Investment income, nonoperating   (4)   
Other nonoperating income (expense)(1)  0   
Interest and debt expense(1)      
Net loss:(437)(536)(623)(537)(511)(421)(293)
Other undisclosed net income attributable to parent1     28
Net loss available to common stockholders, diluted:(436)(536)(623)(537)(511)(421)(264)

Comprehensive Income ($ in thousands)

3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
2/29/2016
2/28/2015
Net loss:(437)(536)(623)(537)(511)(421)(293)
Comprehensive loss, net of tax, attributable to parent:(437)(536)(623)(537)(511)(421)(293)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: